Morgan Stanley Pathway Small-Mid Cap Equity ETF MSSM

Morningstar Medalist Rating

Morningstar’s Analysis MSSM

Will MSSM outperform in the future?

Get our overall rating based on a fundamental assessment of the pillars below.

null Morningstar Automated Analysis

Morningstar Automated Analysis

Summary

Morgan Stanley Pathway Sm-Md Cp Eq ETF holds a quantitatively derived Neutral Morningstar Medalist Rating. The rating suggests the model does not express a clear expectation of outperformance or underperformance relative to peers over a full market cycle.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings MSSM

  • Current Portfolio Date
  • Equity Holdings—
  • Bond Holdings—
  • Other Holdings—
  • % Assets in Top 10 Holdings6.0
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

Us Dollars

1.9413M
Cash and Equivalents

Ascendis Pharma AS

0.856M
Healthcare

Viasat Inc

0.624M
Technology

KBR Inc

0.614M
Industrials

Haemonetics Corp

0.614M
Healthcare

Dynatrace Inc Ordinary Shares

0.584M
Technology

BrightSpring Health Services Inc

0.584M
Healthcare

Moderna Inc

0.554M
Healthcare

Texas Capital Bancshares Inc

0.534M
Financial Services

Wintrust Financial Corp

0.524M
Financial Services

Sponsor Center